To investigate the contribution of the glucocorticoid receptor (GR) in skin development and the mechanisms underlying this function, we have analyzed two mouse models in which GR has been functionally inactivated: the knock-out GR -/-mice and the dimerization mutant GR formed colonies with cells of heterogeneous size and morphology that showed increased growth and apoptosis, indicating that GR regulates these processes in a cell-autonomous manner. The activity of ERK1/2 was constitutively augmented in GR -/-skin and MPKs relative to wt, which suggests that GR modulates skin homeostasis, at least partially, by antagonizing ERK function.
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Materials and methods

Animal experimentation
BrdU immunofluorescence
To determine BrdU incorporation in MPKs, 
Results
GR is required for epidermal and hair follicle differentiation during embryogenesis
To investigate the consequences of GR (Table  1) .
Surprisingly, neither the density nor the average length of HF was significantly changed, as assessed by H&E staining (Table 1) .
We also performed electron microscopy studies of GR +/+ and GR -/-18.5 dpc epidermis (Fig. 3A-F represented by the large subunit p20, was already detected in 16.5 dpc wt epidermis although increased processing was observed in 18.5 dpc skin (Fig. 4A, upper panel). This correlated with the appearance of mature filaggrin at 16.5 and 18.5 dpc, as detected by immunoblotting (Fig. 4A, lower panel, arrowhead). Unprocessed and incompletely processed profilaggrin is indicated by a bracket. In contrast, caspase-14 processing was not detected in 16.5 dpc or 18.5 dpc GR null epidermises with undetectable levels of filaggrin at 16.5 dpc and only minor levels at 18.5 dpc (Fig. 4A ).
In addition, caspase-3 was not activated during fetal epidermis development in wt or GR null mice (Fig. 4B) .
In order to determine whether the caspase-14 expression and/or processing was directly regulated by ligand-activated GR, we examined the effect of the GC analog dexamethasone (Dex) on the mRNA and protein levels of procaspase 14 in wt mouse primary keratinocytes (MPKs) (Fig.   4C-E) . Our results showed that Dex, at a concentration inducing MPK differentiation, produced a two-fold increase in the procaspase-14 protein levels without eliciting its processing (Fig. 4D) .
We also checked whether Dex regulated caspase-14 at the mRNA level and found no differences in caspase-14A and -14B transcripts (Fig. 4E ). In agreement with this, both caspase-14 mRNA forms were similar in GR -/-skin as compared to GR +/+ (Fig. 4E) .
GR inhibits keratinocyte growth in a cellautonomous manner.
The high immaturity of GR -/-epidermis suggested a defective switch between proliferation and differentiation. We observed that immunolocalization of K5, normally restricted to the proliferative single BL (Fig. 5A, arrows) , was abnormally found in suprabasal layers of GR -/-skin (Fig. 5B, arrowheads) . This finding prompted us to examine whether these K5-positive keratinocytes were indeed proliferating by assessing in vivo BrdU incorporation (Fig. 5C-E) . In contrast to control mouse skin, in which all positive nuclei were located in the epidermal BL or in the outer root sheath of HFs (Fig. 5C (Fig. 6 ). Given that epidermal differentiation is severely impaired in GR -/-embryos ( Fig. 1-3 
Contribution of ERK to the impaired keratinocyte function of GR -/-mice
Given the key role of MAPKs in dpc embryos (Fig. 7) . Despite ERK1/2 protein levels being unaltered, p-ERK1/2 (Thr202/Tyr204, which leads to its activation) was increased an average 3.5-fold in GR -/-skin as compared to controls (Fig. 7B ). Immunostaining showed a marked augment of both cytosolic and nuclear p-ERK staining in GR -/-epidermal keratinocytes (Fig. 7C, p-ERK) . In contrast to control epidermis, where p-ERK predominantly localized to GL nuclei, p-ERK was detected throughout all suprabasal layers. However, JNK and p-JNK protein levels were unchanged in GRdeficient skin with no major changes in their cellular distribution (Fig. 7A, C) .
Moreover, phosphorylation of c-jun on residues S63/S73 as well as total c-jun protein levels remained unchanged in GR -/-epidermis relative to wt (Fig. 7A, C (Fig. 9A ). In addition, we found no differences in the expression and localization of the markers of keratinocyte proliferation and differentiation K5, K10
and loricrin (Fig. 9B) . (Fig. 4) . The importance of caspase-14 as a GR target is supported by the recent findings in caspase-14 -/-mice. These mice exhibited reduced skin-hydration levels and increased water loss and an altered profilaggrin processing pattern that could explain the observed phenotype (30).
However, other proteolytic enzymes of this family, such as caspase-1 and -4 have been described as GC-targets in keratinocytes (19).
Remarkably, and despite the reported anti-proliferative role of GR, GR null mice did not show overall increased epidermal proliferation in vivo (Fig. 5) .
However, we observed abnormal proliferating suprabasal keratinocytes in GR -/-skin that indicated a defective switch between proliferation and differentiation.
When MPKs were cultured, an increased proliferation rate of GR -/-keratinocytes as compared to wt was apparent (Fig. 5) , thus demonstrating that GR regulates keratinocyte proliferation in a cellautonomous manner.
GR modulates ERK activity to regulate keratinocyte function
Since MAPK/AP-1 signaling pathway plays a relevant role in keratinocyte biology (reviewed in 31), and given that GR inhibits MAPK function in several cell types, we analyzed whether ERK and JNK activities were altered in GR-deficient keratinocytes.
We found an increase in p-ERK1/2 but not JNK activity in GR -/-keratinocytes by Experiments were performed in duplicate by using four mice of each genotype (n = 4). Bar: 50 µm. TNF-α (100 mg/ml) plus cycloheximide (CHX, 1 µg/ml) was added to wt MPKs for 16h as a positive control for apoptosis. Three different experiments using three replicates for each experimental condition were performed and differences assessed by the t test. Asterisks indicate statistically significant differences relative to wt MPKs, * p < 0.0001. Apoptotic rate of GR -/-MPKs treated with PD98059 also had statistical significance as compared to untreated GR -/-MPKs, p < 0.001. Bayo, Fig.8 
